By Nigam Arora & Dr. Natasha Arora
The Arora Report published Coronavirus Recovery Portfolio when these stocks were trading much lower and many investors were still buying ‘stay-at-home’ stocks. Now there are significant gains in the Arora Coronavirus Recovery Portfolio while those investors who were buying stay-at-home stocks are sitting on large losses. One good way to win is to get ahead of the crowd but not be too early.
Aluminum company Arconic (ARNC) is one of the stocks in the Arora Coronavirus Recovery Portfolio that has made a substantial move up recently.
Our method calls for selling into strength when the crowd is buying. ARNC is long from an average price of $22.31. It is trading at $36.44 as of this writing. This represents a gain of 63%. Right now the crowd is buying the stock and analysts are issuing buy signals. This is the perfect time to take partial profits on one-half of the position if you have not previously taken partial profits on this position.
Consider holding the rest.
The Plan
The Plan is to let the remaining half run further. At the same time, if the stock does pull back, the plan is to add to the position. Such a pull back may also allow an opportunity for those not in the stock to buy. Consider being patient. If and when appropriate, there will be a post in ZYX Buy with the new buy zone, recommended quantity, stop zone, and target zone.
Trades posted on The Arora Report Market Blog have produced unrivalled performance since 2007. These trades have been scrutinized in real-time by thousands of investors across the globe. This provides easy verification of performance for newcomers to this site. Only those trades are included in the performance where the entry post was made available to subscribers to The Arora Report Market Blog. When the entry post is made available only to the paying subscribers and not posted in real-time on The Arora Report Market Blog, the resulting performance of the trade is not credited in the performance table. There are very nice gains on this trade but since the entry trade was not posted here for the free subscribers in real-time but only made available to the paying subscribers, handsome profits on this trade will not be added to the performance of The Arora Report Market Blog shown on the table.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
